The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Nationwide Survey on Complementary and Alternative Medicine in Cancer Patients in Japan
Open accessAbstract
Purpose: To determine the prevalence of use of complementary and alternative medicine (CAM) by patients with cancer in Japan, and to compare the characteristics of CAM users and CAM nonusers. Patients and Methods: A questionnaire on cancer CAM and the Hospital Anxiety and Depression Scale were delivered to 6,607 patients who were treated in 16 cancer centers and 40 palliative care units. Results: There were 3,461 available replies for a response rate of 52.4%. The prevalence of CAM use was 44.6% (1,382 of 3,100) in cancer patients and 25.5% (92 of 361) in noncancer patients with benign tumors. Multiple logistic regression analysis determined that history of chemotherapy, institute (palliative care units), higher education, an altered outlook on life after cancer diagnosis, primary cancer site, and younger age were strongly associated with CAM use in cancer patients. Most of the CAM users with cancer (96.2%) used products such as mushrooms, herbs, and shark cartilage. The motivation for most CAM use was recommendation from family members or friends (77.7%) rather than personal choice (23.3%). Positive effects were experienced by 24.3% of CAM users with cancer, although all of them received conventional cancer therapy concurrently. Adverse reactions were reported by 5.3% of cancer patients. CAM products were used without sufficient information by 57.3% of users with cancer and without a consultation with a doctor by 60.7% of users. Conclusion: This survey revealed a high prevalence of CAM use among cancer patients, without sufficient information or consultation with their physicians. Oncologists should not ignore the CAM products used by their patients because of a lack of proven efficacy and safety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Eisenberg, D. M., Davis, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompay, M., & Kessler, R. C. (1998) · JAMA · doi:10.1001/jama.280.18.1569 · Cited by 6,658
Richardson, M. A., Sanders, T., Palmer, J. L., Greisinger, A., & Singletary, S. E. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2505 · Cited by 1,022
The prevalence of complementary/Alternative medicine in cancer: A systematic review
Ernst, E. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980815)83:4<777::aid-cncr22>3.0.co;2-o · Cited by 891
Effects of St. John's wort on irinotecan metabolism.
Mathijssen, R. H. J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1247 · Cited by 457
Boon, H., Stewart, M., Kennard, M. A., Gray, R., Sawka, C., Brown, J. B., McWilliam, C., Gavin, A., Baron, R. A., Aaron, D., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2515 · Cited by 439
CASSILETH, B. R., LUSK, E. J., STROUSE, T. B., & BODENHEIMER, B. J. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-105 · Cited by 411
Screening for Psychological Distress in Japanese Cancer Patients
Kugaya, A., Akechi, T., Okuyama, T., Okamura, H., & Uchitomi, Y. (1998) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/28.5.333 · Cited by 365
Chen, X., & Siu, L. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.23.4291 · Cited by 262
Botanical Medicines — The Need for New Regulations
Marcus, D. M., & Grollman, A. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmsb022858 · Cited by 253
Determinants of the Use of Complementary Therapies by Patients With Cancer
Paltiel, O., Avitzour, M., Peretz, T., Cherny, N., Kaduri, L., Pfeffer, R. M., Wagner, N., & Soskolne, V. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2439 · Cited by 242
Popularity of complementary and alternative medicine in Japan: a telephone survey
Yamashita, H., Tsukayama, H., & Sugishita, C. (2002) · Complementary Therapies in Medicine · doi:10.1054/ctim.2002.0519 · Cited by 208
Shark Cartilage Contains Inhibitors of Tumor Angiogenesis
Lee, A., & Langer, R. (1983) · Science · doi:10.1126/science.6193581 · Cited by 206
Patterns of alternative medicine use by cancer patients
Begbie, S. D., Kerestes, Z., & Bell, D. R. (1996) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1996.tb138639.x · Cited by 157
Medicinal Herbs in the United States: Research Needs
Matthews, H. B., Lucier, G. W., & Fisher, K. D. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107773 · Cited by 150
Cancer patients use of nonproven therapy: a 5-year follow-up study.
Risberg, T., Lund, E., Wist, E., Kaasa, S., & Wilsgaard, T. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.6 · Cited by 130
Herb-drug interactions: potentially important but woefully under-researched
Ernst, E. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280000194 · Cited by 120
Hyodo, I., Eguchi, K., Nishina, T., Endo, H., Tanimizu, M., Mikami, I., Takashima, S., & Imanishi, J. (2003) · Cancer · doi:10.1002/cncr.11402 · Cited by 101
Self-citationJacobson, J. S., Workman, S., & Kronenberg, F. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.668 · Cited by 97
Discussing Complementary Therapies With Cancer Patients: What Should We Be Talking About?
Burstein, H. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2501 · Cited by 69
The role of complementary and alternative medicine in cancer
Ernst, E. (2000) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00031-0 · Cited by 63
Unproven methods in cancer: a worldwide problem
Schraub, S. (2000) · Supportive Care in Cancer · doi:10.1007/s005209900057 · Cited by 36
St. John's Wort: More Implications for Cancer Patients
Mansky, P. J. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.16.1187 · Cited by 33
Eguchi, K., Hyodo, I., & Saeki, H. (2000) · Supportive Care in Cancer · doi:10.1007/s005209900039 · Cited by 28
Self-citationPsychological impact of informed consent in hospitalized cancer patients
Hyodo, I., Eguchi, K., Takigawa, N., Segawa, Y., Hosokawa, Y., Kamejima, K., & Inoue, R. (1999) · Supportive Care in Cancer · doi:10.1007/s005200050299 · Cited by 27
Self-citationResearch of complementary/alternative medicine therapies in oncology: promising but challenging.
Ma, R. (1999) · PubMed · Cited by 24
Cited by
The amazing potential of fungi: 50 ways we can exploit fungi industrially
Hyde, K. D., Xu, J., Rapior, S., Jeewon, R., Lumyong, S., Niego, A. G. T., Abeywickrama, P. D., Aluthmuhandiram, J. V. S., Brahamanage, R. S., Brooks, S., et al. (2019) · Fungal Diversity · doi:10.1007/s13225-019-00430-9 · Cited by 811
Davis, E. L., Oh, B., Butow, P. N., Mullan, B. A., & Clarke, S. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0223 · Cited by 346
Dobos, G., Overhamm, T., Büssing, A., Ostermann, T., Langhorst, J., Kümmel, S., Paul, A., & Cramer, H. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2660-6 · Cited by 54
Teo, D. C. H., Ng, P. S. L., Tan, S. H., Lim, A. T., Toh, D. S. L., Chan, S. Y., & Cheong, H. H. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1168-z · Cited by 34
Franco, C., Amutio, A., Mañas, I., Sánchez-Sánchez, L. C., & Mateos-Pérez, E. (2020) · International Journal of Stress Management · doi:10.1037/str0000120 · Cited by 21
Metadata
- Authors
- Hyodo, I., Amano, N., Eguchi, K., Narabayashi, M., Imanishi, J., Hirai, M., Nakano, T., & Takashima, S.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-04-20
- Volume
- 23
- Issue
- 12
- Pages
- 2645-2654
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2121307471
- Cited by
- 346
- References
- 26
- FWCI
- 32.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.